𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients

✍ Scribed by Shun-Fa Yang; Yih-Shou Hsieh; Chiao-Lin Lin; Nan-Yung Hsu; Hui-Ling Chiou; Fen-Pi Chou; Shu-Chen Chu

Book ID
116350060
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
220 KB
Volume
354
Category
Article
ISSN
0009-8981

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel inhibitors of urokinase-type plasm
Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines
✍ Kristina Cakarovski; Jenny Y. Leung; Christina Restall; Anna Carin-Carlson; Euni πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 339 KB πŸ‘ 1 views

## Abstract The plasminogen‐activating (PA) and matrix metalloproteinase (MMP) enzyme systems are implicated in proteolytic turnover of the extracellular matrix (ECM) associated with biologic processes including wound healing, inflammation and angiogenesis. Aberrant expression of components of the

Silibinin inhibits the invasion of human
Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2
✍ Shu-Chen Chu; Hui-Ling Chiou; Pei-Ni Chen; Shun-Fa Yang; Yih-Shou Hsieh πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 197 KB

## Abstract Cancer metastasis, involving multiple processes and various cytophysiological changes, is a primary cause of cancer death and may complicate the clinical management, even lead to death. Silibinin is a flavonoid antioxidant and wildly used for its antihepatotoxic properties and recent st